These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37345365)

  • 1. The role of stress hyperglycemia and hyperlactatemia in non-diabetic patients with myocardial infarction treated with percutaneous coronary intervention.
    Terlecki M; Kocowska-Trytko M; Pavlinec C; Ostrowska A; Lis P; Bednarski A; Wojciechowska W; Stolarz-Skrzypek K; Rajzer M
    Cardiol J; 2024; 31(4):573-582. PubMed ID: 37345365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study.
    Qiao Z; Bian X; Song C; Zhang R; Yuan S; Lin Z; Zhu C; Liu Q; Ma W; Dou K
    Cardiovasc Diabetol; 2024 Jun; 23(1):190. PubMed ID: 38824608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High admission glucose levels predict worse short-term clinical outcome in non-diabetic patients with acute myocardial infraction: a retrospective observational study.
    Ding XS; Wu SS; Chen H; Zhao XQ; Li HW
    BMC Cardiovasc Disord; 2019 Jul; 19(1):163. PubMed ID: 31272376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
    Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
    Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, predictors and outcomes of stress hyperglycemia in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Khalfallah M; Abdelmageed R; Elgendy E; Hafez YM
    Diab Vasc Dis Res; 2020; 17(1):1479164119883983. PubMed ID: 31726871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Is Associated With Reduced Stress Hyperlactatemia in Cardiac Surgery.
    Greco G; Kirkwood KA; Gelijns AC; Moskowitz AJ; Lam DW
    Diabetes Care; 2018 Mar; 41(3):469-477. PubMed ID: 29263164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of acid‑base balance parameters assessed on admission in peripheral venous blood of patients with myocardial infarction treated with percutaneous coronary intervention.
    Terlecki M; Kocowska-Trytko M; Plens K; Drożdż T; Pavlinec C; Gruszka K; Klima Ł; Wojciechowska W; Wordliczek J; Stolarz-Skrzypek K; Rajzer M
    Pol Arch Intern Med; 2022 Jun; 132(6):. PubMed ID: 35289158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study.
    Ritsinger V; Jensen J; Ohm D; Omerovic E; Koul S; Fröbert O; Erlinge D; James S; Lagerqvist B; Norhammar A
    Diab Vasc Dis Res; 2019 Nov; 16(6):582-584. PubMed ID: 31476896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent hyperglycemia is an independent predictor of outcome in acute myocardial infarction.
    van der Horst IC; Nijsten MW; Vogelzang M; Zijlstra F
    Cardiovasc Diabetol; 2007 Feb; 6():2. PubMed ID: 17284309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention.
    Yang Y; Kim TH; Yoon KH; Chung WS; Ahn Y; Jeong MH; Seung KB; Lee SH; Chang K
    Int J Cardiol; 2017 Aug; 241():57-63. PubMed ID: 28256326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization.
    Nusca A; Patti G; Marino F; Mangiacapra F; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):377-84. PubMed ID: 21681905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.
    Planer D; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Xu K; Fahy M; Mehran R; Stone GW
    Int J Cardiol; 2013 Sep; 167(6):2572-9. PubMed ID: 22795245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress hyperlactatemia modifies the relationship between stress hyperglycemia and outcome: a retrospective observational study.
    Kaukonen KM; Bailey M; Egi M; Orford N; Glassford NJ; Marik PE; Bellomo R
    Crit Care Med; 2014 Jun; 42(6):1379-85. PubMed ID: 24561567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era.
    Ishihara M; Kagawa E; Inoue I; Kawagoe T; Shimatani Y; Kurisu S; Nakama Y; Maruhashi T; Ookawa K; Dai K; Aokage Y
    Am J Cardiol; 2007 Jun; 99(12):1674-9. PubMed ID: 17560874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.